150 related articles for article (PubMed ID: 26050796)
21. Warfarin pharmacogenetics.
Johnson JA; Cavallari LH
Trends Cardiovasc Med; 2015 Jan; 25(1):33-41. PubMed ID: 25282448
[TBL] [Abstract][Full Text] [Related]
22. A Novel Admixture-Based Pharmacogenetic Approach to Refine Warfarin Dosing in Caribbean Hispanics.
Duconge J; Ramos AS; Claudio-Campos K; Rivera-Miranda G; Bermúdez-Bosch L; Renta JY; Cadilla CL; Cruz I; Feliu JF; Vergara C; Ruaño G
PLoS One; 2016; 11(1):e0145480. PubMed ID: 26745506
[TBL] [Abstract][Full Text] [Related]
23. Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects.
de Oliveira Magalhães Mourão A; Braga Gomes K; Afonso Reis E; Pedra de Souza R; de Freitas Campos EI; Dias Ribeiro D; da Costa Rocha MO; Parreiras Martins MA
Pharmacogenomics J; 2020 Feb; 20(1):104-113. PubMed ID: 31395958
[TBL] [Abstract][Full Text] [Related]
24. Validating two international warfarin pharmacogenetic dosing algorithms for estimating the maintenance dose for patients in Singapore.
Soh SPY; See Toh WY; Ten WQ; Leong KP; Goh LL
Ann Acad Med Singap; 2024 Mar; 53(3):208-210. PubMed ID: 38920246
[No Abstract] [Full Text] [Related]
25. Pharmacogenetic Warfarin Dosing Algorithms: Validity in Egyptian Patients.
Selim TE; Azzam HA; Ghoneim HR; Mohamed AA; El Wakeel H; Abu Bakr HM
Acta Haematol; 2018; 139(4):255-262. PubMed ID: 29996126
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.
Nagai R; Ohara M; Cavallari LH; Drozda K; Patel SR; Nutescu EA; Perera MA; Hernandez W; Kaneko N; Hibiya M; Takahashi H
Pharmacogenomics; 2015; 16(3):217-25. PubMed ID: 25712185
[TBL] [Abstract][Full Text] [Related]
27. What is the role of pharmacogenetics in optimization of warfarin dosing?
Carnes CA
Trends Cardiovasc Med; 2015 Jan; 25(1):42-3. PubMed ID: 25476743
[No Abstract] [Full Text] [Related]
28. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
[TBL] [Abstract][Full Text] [Related]
29. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials.
Stergiopoulos K; Brown DL
JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087
[TBL] [Abstract][Full Text] [Related]
30. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population.
Tavares LC; Duarte NE; Marcatto LR; Soares RAG; Krieger JE; Pereira AC; Santos PCJL
Eur J Clin Pharmacol; 2018 Dec; 74(12):1555-1566. PubMed ID: 30051215
[TBL] [Abstract][Full Text] [Related]
31. Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting.
Sasaki T; Tabuchi H; Higuchi S; Ieiri I
Pharmacogenomics; 2009 Aug; 10(8):1257-66. PubMed ID: 19663670
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.
Palacio L; Falla D; Tobon I; Mejia F; Lewis JE; Martinez AF; Arcos-Burgos M; Camargo M
Clin Appl Thromb Hemost; 2010 Feb; 16(1):83-90. PubMed ID: 19567378
[TBL] [Abstract][Full Text] [Related]
33. Influence of CYP2C9 and vitamin k oxide reductase complex (VKORC)1 polymorphisms on time to determine the warfarin maintenance dose.
Aomori T; Obayashi K; Fujita Y; Araki T; Nakamura K; Nakamura T; Kurabayashi M; Yamamoto K
Pharmazie; 2011 Mar; 66(3):222-5. PubMed ID: 21553655
[TBL] [Abstract][Full Text] [Related]
34. Optimisation of warfarin-dosing algorithms for Han Chinese patients with CYP2C9*13 variants.
Wang D; Wu H; Zhang Q; Zhou X; An Y; Zhao A; Chong J; Wang S; Wang F; Yang J; Dai D; Chen H
Eur J Clin Pharmacol; 2023 Oct; 79(10):1315-1320. PubMed ID: 37458773
[TBL] [Abstract][Full Text] [Related]
35. Variability of warfarin dose response associated with CYP2C9 and VKORC1 gene polymorphisms in Chinese patients.
Ye C; Jin H; Zhang R; Sun Y; Wang Z; Sun W; Sun W; Peng Q; Liu R; Huang Y
J Int Med Res; 2014 Feb; 42(1):67-76. PubMed ID: 24287930
[TBL] [Abstract][Full Text] [Related]
36. Extremely low warfarin dose in patients with genotypes of CYP2C9*3/*3 and VKORC1-1639A/A.
Gao L; He L; Luo J; Xu B; Yang J; Zhang YX; Yang T; Li K; Tian JW; Wang HJ; Zhao YS; Lu CY; Zhang WZ; Yin T
Chin Med J (Engl); 2011 Sep; 124(17):2767-70. PubMed ID: 22040439
[TBL] [Abstract][Full Text] [Related]
37. Ensemble of machine learning algorithms using the stacked generalization approach to estimate the warfarin dose.
Ma Z; Wang P; Gao Z; Wang R; Khalighi K
PLoS One; 2018; 13(10):e0205872. PubMed ID: 30339708
[TBL] [Abstract][Full Text] [Related]
38. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
Anderson JL; Horne BD; Stevens SM; Woller SC; Samuelson KM; Mansfield JW; Robinson M; Barton S; Brunisholz K; Mower CP; Huntinghouse JA; Rollo JS; Siler D; Bair TL; Knight S; Muhlestein JB; Carlquist JF
Circulation; 2012 Apr; 125(16):1997-2005. PubMed ID: 22431865
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetic-guided and clinical warfarin dosing algorithm assessments with bleeding outcomes risk-stratified by genetic and covariate subgroups.
Dietz N; Ruff C; Giugliano RP; Mercuri MF; Antman EM
Int J Cardiol; 2020 Oct; 317():159-166. PubMed ID: 32505370
[TBL] [Abstract][Full Text] [Related]
40. [Impact of five genetic polymorphisms on inter-individual variation in warfarin maintenance dose].
Huang SW; Xiang DK; Wu HL; Chen BL; An BQ; Li GF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):661-5. PubMed ID: 22161100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
